Search company, investor...

Founded Year

2015

Stage

Acq - P2P | Acquired

Total Raised

$189M

Valuation

$0000 

About Decibel Therapeutics

Decibel Therapeutics (NASDAQ: DBTX) is a clinical-stage biotechnology company. It provides hearing aids and focuses on discovering and developing treatments to repair and restore hearing. The company was founded in 2015 and is based in Boston, Massachusetts. In September 2023, Decibel Therapeutics was acquired by Regeneron Pharmaceuticals.

Headquarters Location

1325 Boylston Street Suite 500

Boston, Massachusetts, 02215,

United States

617-370-8701

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Decibel Therapeutics Patents

Decibel Therapeutics has filed 18 patents.

The 3 most popular patent topics include:

  • Audiology
  • Auditory system
  • Rare diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/26/2020

7/4/2023

Indoles, Antineoplastic drugs, Alkylating antineoplastic agents, Abandoned drugs, Organochlorides

Grant

Application Date

10/26/2020

Grant Date

7/4/2023

Title

Related Topics

Indoles, Antineoplastic drugs, Alkylating antineoplastic agents, Abandoned drugs, Organochlorides

Status

Grant

Latest Decibel Therapeutics News

Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped from S&P TMI Index

Sep 25, 2023

Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped from S&P TMI Index September 25, 2023 at 12:00 am EDT Share Share Stocks mentioned in the article Add to a list CI DJ MT Decibel Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing transformative treatments for hearing and balance disorder. It is focused on restoring and improving hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. The Company has built a platform that integrates single-cell genomics and bioinformatics analyses, precision gene therapy technologies and its proficiency in inner ear biology. The Company's pipeline product includes its gene therapy program, namely DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin (OTOF) deficiency. In addition to its gene therapy product candidate and programs, it is also developing a clinical-stage product candidate, DB-020, for the prevention of cisplatin-induced hearing loss. Its products pipeline also includes AAV.103, AAV.104, DB-ATO and AAV.201. Sector

Decibel Therapeutics Frequently Asked Questions (FAQ)

  • When was Decibel Therapeutics founded?

    Decibel Therapeutics was founded in 2015.

  • Where is Decibel Therapeutics's headquarters?

    Decibel Therapeutics's headquarters is located at 1325 Boylston Street, Boston.

  • What is Decibel Therapeutics's latest funding round?

    Decibel Therapeutics's latest funding round is Acq - P2P.

  • How much did Decibel Therapeutics raise?

    Decibel Therapeutics raised a total of $189M.

  • Who are the investors of Decibel Therapeutics?

    Investors of Decibel Therapeutics include Regeneron Pharmaceuticals, Google Ventures, Third Rock Ventures, SR One, Foresite Capital and 14 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.